Cargando…

Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin

We have previously demonstrated that oral administration of bovine lactoferrin (bLF) markedly increases CD4(+) and CD8(+) T cells and NK (asialoGM1(+)) cells in the blood of tumor‐bearing mice and enhances anti‐metastatic activity. In this paper, we document that oral administration of bLF and bLF‐h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen‐Ping, Iigo, Masaaki, Sato, Jun, Sekine, Kazunori, Adachi, Isamu, Tsuda, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926262/
https://www.ncbi.nlm.nih.gov/pubmed/11050473
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00880.x
_version_ 1783318865159127040
author Wang, Wen‐Ping
Iigo, Masaaki
Sato, Jun
Sekine, Kazunori
Adachi, Isamu
Tsuda, Hiroyuki
author_facet Wang, Wen‐Ping
Iigo, Masaaki
Sato, Jun
Sekine, Kazunori
Adachi, Isamu
Tsuda, Hiroyuki
author_sort Wang, Wen‐Ping
collection PubMed
description We have previously demonstrated that oral administration of bovine lactoferrin (bLF) markedly increases CD4(+) and CD8(+) T cells and NK (asialoGM1(+)) cells in the blood of tumor‐bearing mice and enhances anti‐metastatic activity. In this paper, we document that oral administration of bLF and bLF‐hydrolysate (bLFH) is associated with strong increases in CD4(+) and CD8(+) T, as well as asialoGM1(+) cells in lymphoid tissues and lamina propria of the small intestine in mice, especially in tumor‐bearing animals in which Co26Lu cells were implanted subcutaneously. Moreover, IgM(+) and IgA(+) B cells in lamina propria of the small intestine were also significantly increased by bLF and bLFH. Bovine apo‐transferrin (bTF) did not exhibit such activity. In the colon, only CD8(+) cells were significantly increased by treatment with bLF, while asialoGM1(+) cells were significantly decreased. bLF and bLFH induced cytokines to activate T, B and asialoGM1(+) cells. Administration of bLF and bLFH, but not bTF, increased production of interleukin‐18 (IL‐18), interferon‐gamma (IFN‐γ) and caspase‐1 in the mucosa of the small intestine. Particularly high levels of IL‐18 were found in the epithelial cells of the small intestine. Moreover, administration of bLF and bLFH, but not bTF, induced IFN‐γ presenting cells in the small intestine. Caspase‐1, which processes proIL‐18 to mature IL‐18, was also induced in the epithelial cells of the small intestine following treatment with bLF and bLFH, but not with bTF. These results suggest that enhanced production of IL‐18 and IFN‐γ and caspase‐1 induction by treatment with bLF may be important for elevation of intestinal mucosal immunity.
format Online
Article
Text
id pubmed-5926262
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59262622018-05-11 Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin Wang, Wen‐Ping Iigo, Masaaki Sato, Jun Sekine, Kazunori Adachi, Isamu Tsuda, Hiroyuki Jpn J Cancer Res Rapid Communication We have previously demonstrated that oral administration of bovine lactoferrin (bLF) markedly increases CD4(+) and CD8(+) T cells and NK (asialoGM1(+)) cells in the blood of tumor‐bearing mice and enhances anti‐metastatic activity. In this paper, we document that oral administration of bLF and bLF‐hydrolysate (bLFH) is associated with strong increases in CD4(+) and CD8(+) T, as well as asialoGM1(+) cells in lymphoid tissues and lamina propria of the small intestine in mice, especially in tumor‐bearing animals in which Co26Lu cells were implanted subcutaneously. Moreover, IgM(+) and IgA(+) B cells in lamina propria of the small intestine were also significantly increased by bLF and bLFH. Bovine apo‐transferrin (bTF) did not exhibit such activity. In the colon, only CD8(+) cells were significantly increased by treatment with bLF, while asialoGM1(+) cells were significantly decreased. bLF and bLFH induced cytokines to activate T, B and asialoGM1(+) cells. Administration of bLF and bLFH, but not bTF, increased production of interleukin‐18 (IL‐18), interferon‐gamma (IFN‐γ) and caspase‐1 in the mucosa of the small intestine. Particularly high levels of IL‐18 were found in the epithelial cells of the small intestine. Moreover, administration of bLF and bLFH, but not bTF, induced IFN‐γ presenting cells in the small intestine. Caspase‐1, which processes proIL‐18 to mature IL‐18, was also induced in the epithelial cells of the small intestine following treatment with bLF and bLFH, but not with bTF. These results suggest that enhanced production of IL‐18 and IFN‐γ and caspase‐1 induction by treatment with bLF may be important for elevation of intestinal mucosal immunity. Blackwell Publishing Ltd 2000-10 /pmc/articles/PMC5926262/ /pubmed/11050473 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00880.x Text en
spellingShingle Rapid Communication
Wang, Wen‐Ping
Iigo, Masaaki
Sato, Jun
Sekine, Kazunori
Adachi, Isamu
Tsuda, Hiroyuki
Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
title Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
title_full Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
title_fullStr Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
title_full_unstemmed Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
title_short Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
title_sort activation of intestinal mucosal immunity in tumor‐bearing mice by lactoferrin
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926262/
https://www.ncbi.nlm.nih.gov/pubmed/11050473
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00880.x
work_keys_str_mv AT wangwenping activationofintestinalmucosalimmunityintumorbearingmicebylactoferrin
AT iigomasaaki activationofintestinalmucosalimmunityintumorbearingmicebylactoferrin
AT satojun activationofintestinalmucosalimmunityintumorbearingmicebylactoferrin
AT sekinekazunori activationofintestinalmucosalimmunityintumorbearingmicebylactoferrin
AT adachiisamu activationofintestinalmucosalimmunityintumorbearingmicebylactoferrin
AT tsudahiroyuki activationofintestinalmucosalimmunityintumorbearingmicebylactoferrin